https://european-biotechnology.com/wp-content/uploads/2024/04/EPFL_aerial_view.jpg..jpeg8641536Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-14 11:59:452024-07-09 12:37:01Vandria SA bags CHF18m in Series A financing
https://european-biotechnology.com/wp-content/uploads/2024/04/PI_Sino_1860_1046_Mittel.png360640Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-13 09:17:002024-04-02 15:50:43Cell-free protein synthesis systems
The European Court of Justice ruling from 2018 which put the latest breeding methods under the EU GMO legislation was a huge pushback for plant breeding innovation in the EU. With the proposal for a new regulation for certain new genomic techniques (NGTs) published on 5 July 2023, some faith in a rebirth of plant breeding innovation may just start to return.
Antibiotics specialist Antabio SAS has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from existing investors.
https://european-biotechnology.com/wp-content/uploads/2024/04/investment__c__Nature_Design.jpeg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-12 13:11:112024-07-09 13:06:33Antabio SAS raises €25 m in Series B financing
https://european-biotechnology.com/wp-content/uploads/2024/04/VTT_coffee.png10341574Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-12 13:00:182024-07-09 13:05:35Production process for cell-based coffee published
This scrappy young city in the heart of Europe is rapidly becoming a magnet for successful start-ups and companies looking for plenty of room to grow, as well as a culture of cooperation and trust.
At the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the adapted version of the EU Commission’s draft regulation on new genomic techniques.
Sorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.
https://european-biotechnology.com/wp-content/uploads/2024/04/Carthera-Sonocloud-9.png487650Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-12-11 15:22:052024-07-09 13:03:14Cathera SA closes Series B round at €42m
On the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.
French parliamentarians against cell-based meat
Latest NewsThe French Republicans have tabled a bill in the National Assembly aimed at banning the commercialisation of cell-based meat in France.
Vandria SA bags CHF18m in Series A financing
Latest NewsLausanne-based Vandria SA has cashed in CHF18m in a Series A financing led by ND Capital to drive clinical development of VNA-318.
Cell-free protein synthesis systems
ProductsCell-free protein synthesis (CFPS) systems allow rapid protein production in vitro without the need for living cells, offering distinct advantages.
Plant breeding innovation reloaded?
OpinionThe European Court of Justice ruling from 2018 which put the latest breeding methods under the EU GMO legislation was a huge pushback for plant breeding innovation in the EU. With the proposal for a new regulation for certain new genomic techniques (NGTs) published on 5 July 2023, some faith in a rebirth of plant breeding innovation may just start to return.
Antabio SAS raises €25 m in Series B financing
Latest NewsAntibiotics specialist Antabio SAS has raised €25m in a Series B financing round with subscriptions from the AMR Action Fund, the EIC Fund and from existing investors.
Production process for cell-based coffee published
Latest NewsScientists led by Heiko Rischer from the Finnish research centre VTT have published the proof of concept for cell-based coffee production.
Leipzig: fast-growing life science ecosystem
Sponsored PublicationsThis scrappy young city in the heart of Europe is rapidly becoming a magnet for successful start-ups and companies looking for plenty of room to grow, as well as a culture of cooperation and trust.
Germany blocks deregulation of NGT breeds
Latest NewsAt the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the adapted version of the EU Commission’s draft regulation on new genomic techniques.
Cathera SA closes Series B round at €42m
Latest NewsSorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials.
UK publishes £2bn vision for engineering biology
Latest NewsOn the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology.